Finding early Indicators of Neurological Damage in Sickle Cell Disease

Recruiting

• Conditions: sickle cell disease; 10018902; stroke; 10005330; 10007963

• Registration Number: NL-OMON35805
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Sickle cell disease
Age 8-16
treated at AMC or Erasmus MC

Exclusion Criteria

Overt stroke
Chronic blood transfusion scheme
The presence of metal in the body
Claustrofobia

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome is progression of brain infarcts on MRI. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome is diminished neurocognitive functioning. </p><br>